Global Neurology Devices Market Industry Market Size, Share and Growth Analysis Report - Forecast Trends and Outlook 2026-2030

The neurology devices market comprises a broad portfolio of products including neurovascular intervention devices, neurostimulation systems, neurosurgical instruments, cerebral spinal fluid management devices, and diagnostic imaging equipment. As of 2025, the market is valued at approximately $12.7 billion, with consistent expansion expected through the coming decade as neurological disorders represent a growing share of global disease burden.

• •Encompasses devices for stroke management, epilepsy, Parkinson's disease, chronic pain, and other neurological conditions
• •Market projections across industry sources range from approximately $21 billion to $65 billion by 2030-2035, depending on whether narrower or broader neurotechnology definitions are used
• •Technological integration of imaging, robotics, and AI-assisted diagnostics is reshaping product development priorities

A primary catalyst for market expansion is the rising global incidence of neurological disorders, including stroke, Alzheimer's disease, Parkinson's disease, and epilepsy, driven in part by aging populations in developed and developing nations alike. Advancements in minimally invasive procedures, such as mechanical thrombectomy for ischemic stroke, have significantly improved clinical outcomes and expanded treatable patient populations.

• •Increasing prevalence of neurological disorders, with an aging global population amplifying demand for diagnostic and therapeutic devices
• •Improved healthcare infrastructure and rising per capita healthcare spending in emerging markets, particularly across Asia-Pacific
• •Ongoing innovation in neurovascular, neurostimulation, and neurosurgical device technologies driving adoption of next-generation treatment options

The market is commonly segmented by product type into neurovascular devices, neurostimulation devices, neurosurgery devices, and diagnostic imaging systems, with neurovascular intervention representing a particularly high-growth segment. North America currently holds the largest market share due to advanced healthcare infrastructure, favorable reimbursement policies, and a high burden of neurological disease.

• •Neurovascular devices segment was valued at approximately $5 billion in 2025, with projections reaching $8.5 billion by 2035
• •North America leads in market share, while Asia-Pacific is the fastest-growing region driven by rising healthcare access and neurological disease burden
• •Europe represents a significant share, supported by established medical device manufacturing ecosystems and strong regulatory frameworks

What are the recent trends and outlook?

Several emerging trends are shaping the future trajectory of the neurology devices market, including the convergence of robotics, artificial intelligence, and digital health platforms with traditional neuro-interventional and surgical technologies. The growing emphasis on value-based care and cost-effective treatment options is expected to drive demand for devices that reduce procedure times, minimize complications, and improve long-term patient outcomes.

• •Robotic-assisted neurosurgery and AI-enabled diagnostic tools are gaining clinical adoption and expected to drive premium product demand
• •Expansion of endovascular treatment capabilities for acute ischemic stroke continues to broaden addressable patient populations globally
• •Long-term outlook remains strongly positive, with projected market values ranging from $21 billion to over $60 billion by 2030-2035 depending on market definition scope